Annovis Bio, Inc. (FRA:07X)
3.970
+0.050 (1.28%)
At close: Dec 5, 2025
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of €103.66 million as of December 5, 2025. Its market cap has increased by 16.44% in one year.
Market Cap
103.66M
Enterprise Value
90.52M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.97
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from 56.82M to 103.66M, an increase of 82.43%. That is a compound annual growth rate of 10.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 105.68M | 57.65% |
| Dec 31, 2024 | 67.03M | -61.39% |
| Dec 29, 2023 | 173.62M | 69.23% |
| Dec 30, 2022 | 102.59M | -18.07% |
| Dec 31, 2021 | 125.22M | 194.78% |
| Dec 31, 2020 | 42.48M | -25.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |